Literature DB >> 28115197

Structural insights into RNA synthesis by the influenza virus transcription-replication machine.

Alexander Pflug1, Maria Lukarska1, Patricia Resa-Infante1, Stefan Reich1, Stephen Cusack2.   

Abstract

Influenza virus is a segmented, negative strand RNA virus with each genome segment being packaged in a distinct ribonucleoprotein particle (RNP). The RNP consists of the heterotrimeric viral RNA-dependent RNA polymerase bound to the conserved 5' and 3' ends of the genome segment (the viral promoter) with the rest of the viral RNA (vRNA) being covered by multiple copies of nucleoprotein. This review focusses on the new insights that recent crystal structures have given into the detailed molecular mechanisms by which the polymerase performs both transcription and replication of the vRNA genome. Promoter binding, in particular that of 5' end, is essential to allosterically activate all polymerase functions. Transcription is initiated by the hijacking of nascent, capped host transcripts by the process of 'cap-snatching', for which the viral polymerase makes an essential interaction with the C-terminal domain (CTD) of cellular RNA polymerase II. The structures allow a coherent mechanistic model of the subsequent cap-snatching, cap-dependent priming, elongation and self-polyadenylation steps of viral mRNA synthesis. During replication, the vRNA is copied without modification into complementary RNA (cRNA) which is packaged into cRNPs. A priming loop located in the polymerase active site is required for the unprimed synthesis of cRNA from vRNA, but is not required for cRNA to vRNA replication due to differences in the mode of initiation of RNA synthesis. Overall a picture emerges of influenza polymerase being a highly complex, flexible and dynamic machine. The challenge remains to understand in more detail how it functions within the RNP and how interacting host factors modulate its activity in the cellular context. Finally, these detailed insights have opened up new opportunities for structure-based antiviral drug design targeting multiple aspects of polymerase function.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-influenza drug design; Cap-snatching; Influenza polymerase; Pol II C-terminal domain; RNA synthesis; Replication; Transcription

Mesh:

Substances:

Year:  2017        PMID: 28115197     DOI: 10.1016/j.virusres.2017.01.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  69 in total

1.  Firefly genomes illuminate parallel origins of bioluminescence in beetles.

Authors:  Timothy R Fallon; Sarah E Lower; Ching-Ho Chang; Manabu Bessho-Uehara; Gavin J Martin; Adam J Bewick; Megan Behringer; Humberto J Debat; Isaac Wong; John C Day; Anton Suvorov; Christian J Silva; Kathrin F Stanger-Hall; David W Hall; Robert J Schmitz; David R Nelson; Sara M Lewis; Shuji Shigenobu; Seth M Bybee; Amanda M Larracuente; Yuichi Oba; Jing-Ke Weng
Journal:  Elife       Date:  2018-10-16       Impact factor: 8.140

2.  Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors.

Authors:  Alexander Pflug; Stephanie Gaudon; Patricia Resa-Infante; Mathilde Lethier; Stefan Reich; Wiebke M Schulze; Stephen Cusack
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

3.  The structure of the influenza A virus genome.

Authors:  Bernadeta Dadonaite; Brad Gilbertson; Michael L Knight; Sanja Trifkovic; Steven Rockman; Alain Laederach; Lorena E Brown; Ervin Fodor; David L V Bauer
Journal:  Nat Microbiol       Date:  2019-07-22       Impact factor: 17.745

4.  Loss of Fitness of Mexican H7N3 Highly Pathogenic Avian Influenza Virus in Mallards after Circulating in Chickens.

Authors:  Sung-Su Youk; Dong-Hun Lee; Christina M Leyson; Diane Smith; Miria Ferreira Criado; Eric DeJesus; David E Swayne; Mary J Pantin-Jackwood
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

5.  PABP1 Drives the Selective Translation of Influenza A Virus mRNA.

Authors:  Cyrus M de Rozières; Alberto Pequeno; Shandy Shahabi; Taryn M Lucas; Kamil Godula; Gourisankar Ghosh; Simpson Joseph
Journal:  J Mol Biol       Date:  2022-01-21       Impact factor: 5.469

6.  Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease.

Authors:  Dominga Rogolino; Lieve Naesens; Jennifer Bartoli; Mauro Carcelli; Laura De Luca; Giorgio Pelosi; Ryjul W Stokes; Ria Van Berwaer; Serena Vittorio; Annelies Stevaert; Seth M Cohen
Journal:  Bioorg Chem       Date:  2021-10-01       Impact factor: 5.275

7.  In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs.

Authors:  Lisa Marie Simon; Edoardo Morandi; Anna Luganini; Giorgio Gribaudo; Luis Martinez-Sobrido; Douglas H Turner; Salvatore Oliviero; Danny Incarnato
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

8.  Prevalence of the SNP rs10774671 of the OAS1 gene in Mexico as a possible predisposing factor for RNA virus disease.

Authors:  María Teresa Sánchez-González; Oscar Cienfuegos-Jiménez; Salomón Álvarez-Cuevas; Antonio Ali Pérez-Maya; Gissela Borrego-Soto; Iván Alberto Marino-Martínez
Journal:  Int J Mol Epidemiol Genet       Date:  2021-06-15

Review 9.  Structure and Function of the Influenza Virus Transcription and Replication Machinery.

Authors:  Ervin Fodor; Aartjan J W Te Velthuis
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

Review 10.  Influenza Virus RNA Synthesis and the Innate Immune Response.

Authors:  Sabrina Weis; Aartjan J W Te Velthuis
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.